These findings highlight the potential of the complexes to accumulate in EGFR‐expressing head and neck squamous cell carcinoma, advancing the development of starch‐based delivery systems and paving the way for further diagnostic and therapeutic applications. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.